Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: Product/Service

Vessel Medical Introduces Lab in a Box: Cutting Edge All-in-one Equipment That Can Turn a 600 Sqft Room into a COVID-19 Testing Lab


Vessel Medical, a provider of medical workflow solutions, supplies, and equipment, introduces their new and innovative Lab in a Box. Turnkey equipment that includes everything needed for professional laboratory level diagnostics, Lab in a Box is set to radically change the landscape of COVID-19 testing. Developed by leading scientists and technicians in partnership with Hamilton Company, Thermo Fisher, Grenova, and award winning diagnostics laboratory, Premier Medical Laboratory Services, Lab in a Box enables a high capacity of onsite diagnostics for hospitals, expanding laboratories, schools, and large companies in need of quick and accurate testing results.

Each turnkey lab solution includes the latest cutting edge technology that is pre-validated ? all that is required is a brief onsite validation before testing can begin. With precision robotic instruments, lab in a box has high throughput liquid handling along with automated, custom-programmable pipetting that decreases human error and result turnaround time. Additionally, Vessel Medical's Laboratory Information System (LIS) that is included reduces the result analysis time while increasing capacity exponentially.

"We developed Lab in a Box with the goal of providing the most efficient solution for companies and organizations to provide quality COVID-19 testing," said Kevin Murdock, Founder of Vessel Medical. "This equipment conveniently provides the most cutting edge technology for accurate testing while saving time and money. We're happy to help protect businesses, organizations and the people who work for them."

At a time when many companies are losing revenue due to COVID-19, in-house testing with Vessel Medical's Lab in a Box will allow for millions of dollars annually saved in testing expenses. For example, a company that processes 3,000 tests per day saves just under $200,000 per day when compared to outsourced testing. And, companies that process 12,000 tests per day save up to $600,000 per day with this turnkey equipment.

The key features of Lab in a Box help companies to begin testing and to maintain a testing flow uninterrupted. Aside from COVID-19 assays, companies, expanding labs, and organizations can easily pivot their workflow to include detection of other common pathogens as well as genetic testing with upper respiratory, antibiotic resistance, pharmacogenomics, cancer risk screening, Flu A & B, and Std/UTI assays.

The following options are available for purchase of Lab in a Box to suit various organization sizes and needs:

To get started with Lab in a Box today, please visit www.covidlabinabox.com or call 866-575-7878.

About Vessel Medical:

Vessel Medical, since its inception in 1991, has been committed to providing physician's offices, hospitals, laboratories and their employees with the right workflow solutions, medical supplies, and medical equipment for their needs. Headquartered in Greenville, SC, Vessel offers a complete line of laboratory equipment, medical supplies, flu vaccines, paper/disposables, injectables, and patient care supplies from the top brands such as Pro Advantage, Kimberly-Clark, Quidel, Procare, 3M, Hemosense, BinaxNow, Bayer/Seimens, and Hypoguard at discount and bulk rates. For more information about Vessel Medical, please call 866.451.MEDS (6337) or visit www.vesselmedical.com.


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: